Results 51 to 60 of about 56,319 (181)
Emerging Microbes and Infections, 2022 HIV-1 latency posts a major obstacle for HIV-1 eradication. Currently, no desirable latency reversing agents (LRAs) have been implicated in the “Shock and Kill” strategy to mobilize the latently infected cells to be susceptible for clearance by immune ...
Jing Wen +12 more
doaj +1 more source
Identify Potential Regulators in HIV-1 Latency by Joint microRNA and mRNA Analysis
Cellular Physiology and Biochemistry, 2015 Background/Aims: The main obstacle to cure HIV infection is the existence of long-lasting latent reservoirs. Many efforts have been made to understand basal mechanisms of HIV-1 latency, in which miRNAs play an important role. However, integrated analysis
Zongxing Yang +6 more
doaj +1 more source
Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles. [PDF]
, 2018 Combination antiretroviral therapy fails in complete suppression of HIV-1 due to drug resistance and persistent latency. Novel therapeutic intervention requires knowledge of intracellular pathways responsible for viral replication, specifically those ...
Arizala, Jerlisa Ann C +5 more
core +1 more source
Latency and viral persistence in HIV-1 infection [PDF]
Journal of Clinical Investigation, 2000 HIV-1 infection can be controlled with combinations of antiretroviral drugs, an approach known as highly active antiretroviral therapy (HAART). In patients who respond well to HAART, viremia decreases to below the limits of detection, disease progression stops, and reconstitution of the immune system begins.
J D, Siliciano, R F, Siliciano
openaire +2 more sources
HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes. [PDF]
, 2009 peer reviewedThe introduction in 1996 of the HAART raised hopes for the eradication of HIV-1. Unfortunately, the discovery of latent HIV-1 reservoirs in CD4+ T cells and in the monocyte-macrophage lineage proved the optimism to be premature.
Aunis, Dominique +8 more
core +3 more sources
[Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
Medecine sciences : M/S, 2010 L’introduction de la multithérapie active en 1996 s’est avérée très efficace et avait entretenu l’espoir d’éradiquer le virus du Sida. Malheureusement, des obstacles à son éradication sont rapidement apparus, notamment la mise en évidence du phénomène de latence virale dans les principales cellules cibles du virus, dont les lymphocytes T CD4+ et les ...
Schwartz, Christian +6 more
openaire +2 more sources
Novel Latency Reversal Agents for HIV-1 Cure [PDF]
Annual Review of Medicine, 2018 Antiretroviral therapy (ART) has rendered HIV-1 infection a treatable illness; however, ART is not curative owing to the persistence of replication-competent, latent proviruses in long-lived resting T cells. Strategies that target these latently infected cells and allow immune recognition and clearance of this reservoir will be necessary to eradicate ...
Adam M, Spivak, Vicente, Planelles
openaire +2 more sources
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents. [PDF]
, 2018 HIV latency in resting CD4+ T cell represents a key barrier preventing cure of the infection with antiretroviral drugs alone. Latency reversing agents (LRAs) can activate HIV expression in latently infected cells, potentially leading to their elimination
DeChristopher, Brian A +11 more
core +1 more source
PLoS Pathogens, 2016 The search for an HIV-1 cure has been greatly hindered by the presence of a viral reservoir that persists despite antiretroviral therapy (ART). Studies of HIV-1 latency in vivo are also complicated by the low proportion of latently infected cells in HIV ...
Cory H White +9 more
doaj +1 more source
Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems [PDF]
, 2015 The recent biotechnology breakthrough of cell reprogramming and generation of induced pluripotent stem cells (iPSCs), which has revolutionized the approaches to study the mechanisms of human diseases and to test new drugs, can be exploited to generate ...
Barzon, Luisa +6 more
core +5 more sources